Low
₹3,054.35
High
₹3,060.94
Low
₹2,976.96
High
₹3,082.15
| Previous Close | ₹3,060.86 |
|---|---|
| Day's Range | ₹3,054.35 - ₹3,060.94 |
| Open | ₹3,060.93 |
| 52 Week Range | ₹2,976.96 - ₹3,082.15 |
| Volume | 0 |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 23211.5 | 26373.20 | 22182.55 |
| Nifty IT | 29558.1 | 40301.40 | 27078.00 |
| Nifty Next 50 | 69296.8 | 72442.15 | 59896.10 |
| NIFTY50 USD Index | 8398.55 | 10443.40 | 8132.40 |
| Nifty Bank | 53170.0 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 60180.1 | 62907.50 | 52032.85 |
| Nifty 500 | 22267.05 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 17034.65 | 17859.10 | 14804.55 |
| Nifty 100 | 24207.2 | 26975.15 | 22720.45 |
| Nifty FMCG | 48035.95 | 58485.05 | 45334.15 |
Pursuant to Regulation 30 of the SEBI Listing Regulations, Bajel Projects has informed that the Company has been awarded a Mega* EPC Orders of EHV Substation, as mentioned in their respective PO/LOA, as per details given in Annexure A. None of the promoter/promoter group/group companies have any interest in the entity that awarded the order/contract. Further, the order/contract would not fall within the purview of related party transaction.
The above information is a part of company’s filings submitted to BSE.
Praj Industries has informed that it enclosed transcript of Analysts’ Call of the company held on 29th May, 2026 regarding Audited Financial Results (Standalone and Consolidated) for the fourth quarter and year ended 31st March, 2026.
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, Corona Remedies has informed that the Officials of the Company will be participating in a Non-Deal Roadshow (NDR) to meet Investors on June 08, 2026 and June 09, 2026 at 09:00 am (SST) onwards organized by IIFL Capital in Singapore (1x1). Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) will be discussed during the said Meetings. This intimation is also being made available on the website of the Company at www.coronaremedies.com.
The above information is a part of company’s filings submitted to BSE.
Pursuant to the compliance with Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shilpa Medicare has informed that Shilpa Biocare (‘Biocare’) - a wholly owned subsidiary of the company, intends to make a Strategic Equity Partnership of 30.4% in Gate2Brain (G2B). The details of the above acquisition (as required to be furnished pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI Listing Regulations and SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026) are enclosed as Annexure A. The above information is also available on the website of the Company www.vbshilpa.com.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The previous close of NIFTYGSCOMP index is ₹3054.83 as of 2026-06-03.
The total volume of NIFTYGSCOMP index is 0.00 as of 2026-06-03.
The percentage change in value of NIFTYGSCOMP index is -0.20% as of 2026-06-03.
The absolute increase in NIFTYGSCOMP index value since the previous trading day is ₹-6.03 as of 2026-06-03.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.